The global Oncology Drug market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Roche Ltd
Novartis AG
Bristol-Myers Squibb
Celgene Corporation
Johnson & Johnson
Pfizer Inc.
Astra Zenca Plc
Eli Lilly And Company.
Glaxosmithkline Plc
Merck & Co.
Sanofi
Amgen Inc.
Abbvie
By Types:
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
By Applications:
Blood Cancer
Breast Cancer
gastrointestinal Tract Cancer
Prostate Cancer
Lung Cancer
Skin Cancer
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Oncology Drug Market Size Analysis from 2022 to 2027
1.5.1 Global Oncology Drug Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Oncology Drug Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Oncology Drug Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Oncology Drug Industry Impact
Chapter 2 Global Oncology Drug Competition by Types, Applications, and Top Regions and Countries
2.1 Global Oncology Drug (Volume and Value) by Type
2.1.1 Global Oncology Drug Consumption and Market Share by Type (2016-2021)
2.1.2 Global Oncology Drug Revenue and Market Share by Type (2016-2021)
2.2 Global Oncology Drug (Volume and Value) by Application
2.2.1 Global Oncology Drug Consumption and Market Share by Application (2016-2021)
2.2.2 Global Oncology Drug Revenue and Market Share by Application (2016-2021)
2.3 Global Oncology Drug (Volume and Value) by Regions
2.3.1 Global Oncology Drug Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Oncology Drug Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Oncology Drug Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Oncology Drug Consumption by Regions (2016-2021)
4.2 North America Oncology Drug Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Oncology Drug Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Oncology Drug Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Oncology Drug Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Oncology Drug Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Oncology Drug Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Oncology Drug Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Oncology Drug Sales, Consumption, Export, Import (2016-2021)
4.10 South America Oncology Drug Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Oncology Drug Market Analysis
5.1 North America Oncology Drug Consumption and Value Analysis
5.1.1 North America Oncology Drug Market Under COVID-19
5.2 North America Oncology Drug Consumption Volume by Types
5.3 North America Oncology Drug Consumption Structure by Application
5.4 North America Oncology Drug Consumption by Top Countries
5.4.1 United States Oncology Drug Consumption Volume from 2016 to 2021
5.4.2 Canada Oncology Drug Consumption Volume from 2016 to 2021
5.4.3 Mexico Oncology Drug Consumption Volume from 2016 to 2021
Chapter 6 East Asia Oncology Drug Market Analysis
6.1 East Asia Oncology Drug Consumption and Value Analysis
6.1.1 East Asia Oncology Drug Market Under COVID-19
6.2 East Asia Oncology Drug Consumption Volume by Types
6.3 East Asia Oncology Drug Consumption Structure by Application
6.4 East Asia Oncology Drug Consumption by Top Countries
6.4.1 China Oncology Drug Consumption Volume from 2016 to 2021
6.4.2 Japan Oncology Drug Consumption Volume from 2016 to 2021
6.4.3 South Korea Oncology Drug Consumption Volume from 2016 to 2021
Chapter 7 Europe Oncology Drug Market Analysis
7.1 Europe Oncology Drug Consumption and Value Analysis
7.1.1 Europe Oncology Drug Market Under COVID-19
7.2 Europe Oncology Drug Consumption Volume by Types
7.3 Europe Oncology Drug Consumption Structure by Application
7.4 Europe Oncology Drug Consumption by Top Countries
7.4.1 Germany Oncology Drug Consumption Volume from 2016 to 2021
7.4.2 UK Oncology Drug Consumption Volume from 2016 to 2021
7.4.3 France Oncology Drug Consumption Volume from 2016 to 2021
7.4.4 Italy Oncology Drug Consumption Volume from 2016 to 2021
7.4.5 Russia Oncology Drug Consumption Volume from 2016 to 2021
7.4.6 Spain Oncology Drug Consumption Volume from 2016 to 2021
7.4.7 Netherlands Oncology Drug Consumption Volume from 2016 to 2021
7.4.8 Switzerland Oncology Drug Consumption Volume from 2016 to 2021
7.4.9 Poland Oncology Drug Consumption Volume from 2016 to 2021
Chapter 8 South Asia Oncology Drug Market Analysis
8.1 South Asia Oncology Drug Consumption and Value Analysis
8.1.1 South Asia Oncology Drug Market Under COVID-19
8.2 South Asia Oncology Drug Consumption Volume by Types
8.3 South Asia Oncology Drug Consumption Structure by Application
8.4 South Asia Oncology Drug Consumption by Top Countries
8.4.1 India Oncology Drug Consumption Volume from 2016 to 2021
8.4.2 Pakistan Oncology Drug Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Oncology Drug Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Oncology Drug Market Analysis
9.1 Southeast Asia Oncology Drug Consumption and Value Analysis
9.1.1 Southeast Asia Oncology Drug Market Under COVID-19
9.2 Southeast Asia Oncology Drug Consumption Volume by Types
9.3 Southeast Asia Oncology Drug Consumption Structure by Application
9.4 Southeast Asia Oncology Drug Consumption by Top Countries
9.4.1 Indonesia Oncology Drug Consumption Volume from 2016 to 2021
9.4.2 Thailand Oncology Drug Consumption Volume from 2016 to 2021
9.4.3 Singapore Oncology Drug Consumption Volume from 2016 to 2021
9.4.4 Malaysia Oncology Drug Consumption Volume from 2016 to 2021
9.4.5 Philippines Oncology Drug Consumption Volume from 2016 to 2021
9.4.6 Vietnam Oncology Drug Consumption Volume from 2016 to 2021
9.4.7 Myanmar Oncology Drug Consumption Volume from 2016 to 2021
Chapter 10 Middle East Oncology Drug Market Analysis
10.1 Middle East Oncology Drug Consumption and Value Analysis
10.1.1 Middle East Oncology Drug Market Under COVID-19
10.2 Middle East Oncology Drug Consumption Volume by Types
10.3 Middle East Oncology Drug Consumption Structure by Application
10.4 Middle East Oncology Drug Consumption by Top Countries
10.4.1 Turkey Oncology Drug Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Oncology Drug Consumption Volume from 2016 to 2021
10.4.3 Iran Oncology Drug Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Oncology Drug Consumption Volume from 2016 to 2021
10.4.5 Israel Oncology Drug Consumption Volume from 2016 to 2021
10.4.6 Iraq Oncology Drug Consumption Volume from 2016 to 2021
10.4.7 Qatar Oncology Drug Consumption Volume from 2016 to 2021
10.4.8 Kuwait Oncology Drug Consumption Volume from 2016 to 2021
10.4.9 Oman Oncology Drug Consumption Volume from 2016 to 2021
Chapter 11 Africa Oncology Drug Market Analysis
11.1 Africa Oncology Drug Consumption and Value Analysis
11.1.1 Africa Oncology Drug Market Under COVID-19
11.2 Africa Oncology Drug Consumption Volume by Types
11.3 Africa Oncology Drug Consumption Structure by Application
11.4 Africa Oncology Drug Consumption by Top Countries
11.4.1 Nigeria Oncology Drug Consumption Volume from 2016 to 2021
11.4.2 South Africa Oncology Drug Consumption Volume from 2016 to 2021
11.4.3 Egypt Oncology Drug Consumption Volume from 2016 to 2021
11.4.4 Algeria Oncology Drug Consumption Volume from 2016 to 2021
11.4.5 Morocco Oncology Drug Consumption Volume from 2016 to 2021
Chapter 12 Oceania Oncology Drug Market Analysis
12.1 Oceania Oncology Drug Consumption and Value Analysis
12.2 Oceania Oncology Drug Consumption Volume by Types
12.3 Oceania Oncology Drug Consumption Structure by Application
12.4 Oceania Oncology Drug Consumption by Top Countries
12.4.1 Australia Oncology Drug Consumption Volume from 2016 to 2021
12.4.2 New Zealand Oncology Drug Consumption Volume from 2016 to 2021
Chapter 13 South America Oncology Drug Market Analysis
13.1 South America Oncology Drug Consumption and Value Analysis
13.1.1 South America Oncology Drug Market Under COVID-19
13.2 South America Oncology Drug Consumption Volume by Types
13.3 South America Oncology Drug Consumption Structure by Application
13.4 South America Oncology Drug Consumption Volume by Major Countries
13.4.1 Brazil Oncology Drug Consumption Volume from 2016 to 2021
13.4.2 Argentina Oncology Drug Consumption Volume from 2016 to 2021
13.4.3 Columbia Oncology Drug Consumption Volume from 2016 to 2021
13.4.4 Chile Oncology Drug Consumption Volume from 2016 to 2021
13.4.5 Venezuela Oncology Drug Consumption Volume from 2016 to 2021
13.4.6 Peru Oncology Drug Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Oncology Drug Consumption Volume from 2016 to 2021
13.4.8 Ecuador Oncology Drug Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Oncology Drug Business
14.1 Roche Ltd
14.1.1 Roche Ltd Company Profile
14.1.2 Roche Ltd Oncology Drug Product Specification
14.1.3 Roche Ltd Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Novartis AG
14.2.1 Novartis AG Company Profile
14.2.2 Novartis AG Oncology Drug Product Specification
14.2.3 Novartis AG Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Bristol-Myers Squibb
14.3.1 Bristol-Myers Squibb Company Profile
14.3.2 Bristol-Myers Squibb Oncology Drug Product Specification
14.3.3 Bristol-Myers Squibb Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Celgene Corporation
14.4.1 Celgene Corporation Company Profile
14.4.2 Celgene Corporation Oncology Drug Product Specification
14.4.3 Celgene Corporation Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Johnson & Johnson
14.5.1 Johnson & Johnson Company Profile
14.5.2 Johnson & Johnson Oncology Drug Product Specification
14.5.3 Johnson & Johnson Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Pfizer Inc.
14.6.1 Pfizer Inc. Company Profile
14.6.2 Pfizer Inc. Oncology Drug Product Specification
14.6.3 Pfizer Inc. Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Astra Zenca Plc
14.7.1 Astra Zenca Plc Company Profile
14.7.2 Astra Zenca Plc Oncology Drug Product Specification
14.7.3 Astra Zenca Plc Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Eli Lilly And Company.
14.8.1 Eli Lilly And Company. Company Profile
14.8.2 Eli Lilly And Company. Oncology Drug Product Specification
14.8.3 Eli Lilly And Company. Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Glaxosmithkline Plc
14.9.1 Glaxosmithkline Plc Company Profile
14.9.2 Glaxosmithkline Plc Oncology Drug Product Specification
14.9.3 Glaxosmithkline Plc Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Merck & Co.
14.10.1 Merck & Co. Company Profile
14.10.2 Merck & Co. Oncology Drug Product Specification
14.10.3 Merck & Co. Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Sanofi
14.11.1 Sanofi Company Profile
14.11.2 Sanofi Oncology Drug Product Specification
14.11.3 Sanofi Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Amgen Inc.
14.12.1 Amgen Inc. Company Profile
14.12.2 Amgen Inc. Oncology Drug Product Specification
14.12.3 Amgen Inc. Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Abbvie
14.13.1 Abbvie Company Profile
14.13.2 Abbvie Oncology Drug Product Specification
14.13.3 Abbvie Oncology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Oncology Drug Market Forecast (2022-2027)
15.1 Global Oncology Drug Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Oncology Drug Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Oncology Drug Value and Growth Rate Forecast (2022-2027)
15.2 Global Oncology Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Oncology Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Oncology Drug Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Oncology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Oncology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Oncology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Oncology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Oncology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Oncology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Oncology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Oncology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Oncology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Oncology Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Oncology Drug Consumption Forecast by Type (2022-2027)
15.3.2 Global Oncology Drug Revenue Forecast by Type (2022-2027)
15.3.3 Global Oncology Drug Price Forecast by Type (2022-2027)
15.4 Global Oncology Drug Consumption Volume Forecast by Application (2022-2027)
15.5 Oncology Drug Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
The Drug Temperature Monitoring System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Small Molecule Drug CDMO Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
Executive Summary
Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...
Executive Summary
Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...
The Intelligent Drug Delivery Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Contract Drug Discovery Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Computer-assisted Drug Design Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
Executive Summary
Azoth Analytics has released a research report titled "Global Therapeutic Antibody Market (2023 Edition)" which provides a complete analysis of the Global Therapeutic Antibody industry in terms of market segmentation By Product Type (Monoclonal Antibody, Bispecific Ant...
Executive Summary
Azoth Analytics has released a research report titled "Global Cephalosporin Drug Market (2024 Edition)" which provides a complete analysis of the Global Cephalosporin Drug industry in terms of market segmentation By Generation (First Generation, Second Generation, Thir...
Executive Summary
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...